| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Urology, University of Washington, Seattle, Washington 98195
The expression of 119 cell surface molecules was catalogued for three prostate cancer cell lines, LNCaP, PC3, and DU145, all of which were established from metastases. Many of these molecules are common to all three cell lines, whereas some are differentially expressed. More prostate basal epithelial cell-specific than luminal epithelial cell-specific molecules are detected, especially in DU145 and PC3 cells. The cancer cells also express molecules that are not normally associated with prostate epithelial cells. As a population, expression of these molecules appears to be heterogeneous. This heterogeneity may be an inherent property of the population.
This article has been cited by other articles:
![]() |
A. Iwase, H. Ando, T. Nagasaka, M. Goto, T. Harata, and F. Kikkawa Distribution of Endothelin-converting Enzyme-1 and Neutral Endopeptidase in Human Endometrium J. Histochem. Cytochem., December 1, 2007; 55(12): 1229 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iwase, H. Ando, T. Nagasaka, D. Shibata, T. Harata, Y. Shimomura, M. Goto, and F. Kikkawa Neutral Endopeptidase Expressed by Decidualized Stromal Cells Suppresses Akt Phosphorylation and Deoxyribonucleic Acid Synthesis Induced by Endothelin-1 in Human Endometrium Endocrinology, November 1, 2006; 147(11): 5153 - 5159. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M Peehl Primary cell cultures as models of prostate cancer development Endocr. Relat. Cancer, March 1, 2005; 12(1): 19 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Liu, M. P. Roudier, and L. D. True Heterogeneity in Primary and Metastatic Prostate Cancer as Defined by Cell Surface CD Profile Am. J. Pathol., November 1, 2004; 165(5): 1543 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Liu and L. D. True Characterization of Prostate Cell Types by CD Cell Surface Molecules Am. J. Pathol., January 1, 2002; 160(1): 37 - 43. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |